Zosano Announces FDA Submission of New Drug Application for Qtrypta

5 years ago

by David Miller

949 Views

Written by David Miller

FREMONT, Calif., Dec. 23, 2019 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the submission of a 505(b)(2) New Drug Application (“NDA”) for…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!